Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Asset Utilization Ratio (2019 - 2025)

BioNexus Gene Lab's Asset Utilization Ratio history spans 7 years, with the latest figure at 1.11 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 32.76% year-over-year to 1.11; the TTM value through Sep 2025 reached 1.11, up 32.76%, while the annual FY2024 figure was 0.87, 10.21% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 1.11 at BioNexus Gene Lab, up from 1.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.7 in Q1 2022 and bottomed at 0.57 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 1.11 (2021), against an average of 1.12.
  • The largest annual shift saw Asset Utilization Ratio plummeted 78.89% in 2021 before it soared 200.11% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 1.38 in 2021, then fell by 4.36% to 1.32 in 2022, then plummeted by 35.33% to 0.85 in 2023, then increased by 3.86% to 0.89 in 2024, then grew by 25.14% to 1.11 in 2025.
  • Per Business Quant, the three most recent readings for BGLC's Asset Utilization Ratio are 1.11 (Q3 2025), 1.01 (Q2 2025), and 0.93 (Q1 2025).